Sep 22, 2023, 18:44
Brian Alexander: Excited about our new collaboration with Gustave Roussy and Roche France to bring liquid biopsy genomic testing to patients in France.
Brian Alexander, CEO of Foundation Medicine, shared on LinkedIn:
“Excited about our new collaboration with Gustave Roussy and Roche France to bring liquid biopsy genomic testing to patients in France.
Cancer is a disease of the genome and it’s critical that physicians have access to high-quality, well-validated genomic tests to inform treatment options for their patients.”
For details click here.
Source: Brian Alexander/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43
Nov 12, 2024, 19:34